SSA
REVH

Schonfeld Strategic Advisors’s Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock REVH Stock Holding History

Schonfeld Strategic Advisors’s Portfolio REVH Stock Details REVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-17,163
Closed -$169K – 3329
2022
Q3 		$169K Hold
17,163
– – ﹤0.01% 2404
2022
Q2 		$168K Buy
17,163
+1,567
+10% +$15.3K ﹤0.01% 1966
2022
Q1 		$153K Buy
15,596
+2,643
+20% +$25.7K ﹤0.01% 2072
2021
Q4 		$126K Hold
12,953
– – ﹤0.01% 1843
2021
Q3 		$126K Buy
+12,953
New +$126K ﹤0.01% 1888

Schonfeld Strategic Advisors's REVH Position: Q4 2022 in Review

Schonfeld Strategic Advisors sold out of Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock (REVH) in Q4 2022, closing a stake of 17,163 shares — an estimated $169K sold.

Schonfeld Strategic Advisors first reported a position in REVH in Q3 2021 and held it in 5 quarters. The position peaked at $169K in Q3 2022. 0 funds tracked by Wall St. Rank hold REVH as of Q4 2022.

  • Schonfeld Strategic Advisors reported no remaining Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 17,163 Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock shares in Q4 2022, an estimated $169K.
  • Schonfeld Strategic Advisors first reported a position in Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock in Q3 2021 and held it in 5 quarters.
  • Schonfeld Strategic Advisors's Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock position peaked at $169K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock as of Q4 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.